Where I see patients (2)
My reviews
Selected research
-
Modulating the PPAR? pathway upregulates NECTIN4 and enhances chimeric antigen receptor (CAR) T cell therapy in bladder cancer.
Nature communications
-
Bladder cancer variants share aggressive features including a CA125+ cell state and targetable TM4SF1 expression.
Nature communications
-
Defining CDK12 as a tumor suppressor and therapeutic target in mouse models of tubo-ovarian high-grade serous carcinoma.
Proceedings of the National Academy of Sciences of the United States of America
4.9